<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    Teligent, Inc.

    Teligent, Inc.

    Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission...

    Teligent is a specialty generic pharmaceutical ...

    Filing Type:    PU
    Rian Enterprises, Inc.

    Rian Enterprises, Inc.

    Health Journal is a leader and influencer in health publishing in Virginia, USA an...

    Health Journal is a leader and influencer in he...

    Amount Raised:    $1,400.00
    Fundraising Status:    EC
    Filing Type:    CF
    InVivo Therapeutics Holdings Corp.

    InVivo Therapeutics Holdings Corp.

    Armed with cutting-edge technology and MIT science, experienced business and medic...

    Armed with cutting-edge technology and MIT scie...

    Filing Type:    PU
    Adverum Biotechnologies, Inc.

    Adverum Biotechnologies, Inc.

    Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...

    Adverum is a clinical-stage gene therapy compan...

    Filing Type:    PU
    MicroGen Vet LLC

    MicroGen Vet LLC

    The next evolution in DNA-based diagnostics. MicroGen Vet is the exclusive reselle...

    The next evolution in DNA-based diagnostics. Mi...

    Amount Raised:    $51,390.00
    Fundraising Status:    EC
    Filing Type:    CF
    Miragen Therapeutics, Inc.

    Miragen Therapeutics, Inc.

    miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discover...

    miRagen Therapeutics, Inc., is a clinical stage...

    Filing Type:    PU
    Aptinyx Inc.

    Aptinyx Inc.

    Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and develop...

    Aptinyx Inc. is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Simulations Plus, Inc.

    Simulations Plus, Inc.

    Simulations Plus, Inc. is the leading developer of Absorption, Distribution, Metab...

    Simulations Plus, Inc. is the leading developer...

    Filing Type:    PU
    Nektar Therapeutics

    Nektar Therapeutics

    Nektar Therapeutics is a research-based development stage biopharmaceutical compan...

    Nektar Therapeutics is a research-based develop...

    Filing Type:    PU
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Progenics Pharmaceuticals Inc.

    Progenics Pharmaceuticals Inc.

    Progenics develops innovative medicines and other technologies to target and treat...

    Progenics develops innovative medicines and oth...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.